Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Discovery Platform
Recipient : BioDuro
Deal Size : Undisclosed
Deal Type : Partnership
Silicogenix Partners with BioDuro to Accelerate Novel Drug Discovery for Complex Diseases
Details : The collaboration combines SGX's novel frameworks with BioDuro's leading drug discovery platform to lower the cost and time barriers in developing complex therapies.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Discovery Platform
Recipient : BioDuro
Deal Size : Undisclosed
Deal Type : Partnership